These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24094935)

  • 21. Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models.
    Mohammadi S; Jones L; Gorbet M
    PLoS One; 2014; 9(9):e106653. PubMed ID: 25207851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chitosan nanoparticles laden contact lenses for enzyme-triggered controlled delivery of timolol maleate: A promising strategy for managing glaucoma.
    Maulvi FA; Patel AR; Shetty KH; Desai DT; Shah DO; Willcox MDP
    Drug Deliv Transl Res; 2024 Nov; 14(11):3212-3224. PubMed ID: 38407770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension.
    Cheng YH; Hung KH; Tsai TH; Lee CJ; Ku RY; Chiu AW; Chiou SH; Liu CJ
    Acta Biomater; 2014 Oct; 10(10):4360-6. PubMed ID: 24914827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latanoprost uptake and release from commercial contact lenses.
    Horne RR; Rich JT; Bradley MW; Pitt WG
    J Biomater Sci Polym Ed; 2020 Jan; 31(1):1-19. PubMed ID: 31526302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study.
    Shoji N; Ogata H; Suyama H; Ishikawa H; Suzuki H; Morita T; Kawai H; Nishimoto H; Nemoto T; Shimizu K
    Curr Med Res Opin; 2005 Apr; 21(4):503-8. PubMed ID: 15899098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment.
    Tripathi S; Yadav KS
    Daru; 2024 Jun; 32(1):161-175. PubMed ID: 38158475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma.
    Fathalla D; Fouad EA; Soliman GM
    Drug Dev Ind Pharm; 2020 May; 46(5):806-813. PubMed ID: 32281424
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacological profiles of latanoprost (Xalatan), a novel anti-glaucoma drug].
    Nomura S; Hashimoto M
    Nihon Yakurigaku Zasshi; 2000 May; 115(5):280-6. PubMed ID: 10872179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension.
    Feldman RM
    Expert Opin Pharmacother; 2004 Apr; 5(4):909-21. PubMed ID: 15102573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma.
    Rulo AH; Greve EL; Geijssen HC; Hoyng PF
    Ophthalmology; 1996 Aug; 103(8):1276-82. PubMed ID: 8764799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selectively coated contact lenses by nanoelectrospray (nES) to fabricate drug-eluting contact lenses for treating ocular diseases.
    Tam CH; Alexander MS; Sanderson J; Qi S
    Med Eng Phys; 2024 Feb; 124():104110. PubMed ID: 38418021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study.
    Schwenn O; Heckmann B; Guzy C; Miller PJ
    BMC Ophthalmol; 2010 Sep; 10():21. PubMed ID: 20825668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: in vitro and in vivo evaluation. Preliminary results.
    Giarmoukakis A; Labiris G; Sideroudi H; Tsimali Z; Koutsospyrou N; Avgoustakis K; Kozobolis V
    Exp Eye Res; 2013 Jul; 112():29-36. PubMed ID: 23603320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents.
    Hoyng PF; Rulo A; Greve E; Watson P; Alm A
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S93-8. PubMed ID: 9154283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of IOP with latanoprost.
    Hoste AM
    Ophthalmology; 1997 Jun; 104(6):895-7. PubMed ID: 9186420
    [No Abstract]   [Full Text] [Related]  

  • 36. Steroid-eluting contact lenses for corneal and intraocular inflammation.
    Bengani LC; Kobashi H; Ross AE; Zhai H; Salvador-Culla B; Tulsan R; Kolovou PE; Mittal SK; Chauhan SK; Kohane DS; Ciolino JB
    Acta Biomater; 2020 Oct; 116():149-161. PubMed ID: 32814140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of latanoprost in the treatment of glaucoma associated with Sturge-Weber syndrome.
    Yang CB; Freedman SF; Myers JS; Buckley EG; Herndon LW; Allingham RR
    Am J Ophthalmol; 1998 Oct; 126(4):600-2. PubMed ID: 9780111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment merits of Latanoprost/Thymoquinone - Encapsulated liposome for glaucomatus rabbits.
    Fahmy HM; Saad EAES; Sabra NM; El-Gohary AA; Mohamed FF; Gaber MH
    Int J Pharm; 2018 Sep; 548(1):597-608. PubMed ID: 29997042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of short-term studies with three dose regimens of latanoprost treatment.
    Greve EL; Rulo AH; Drance SM; Crichton AC; Mills RP; Hoyng PF
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S89-92. PubMed ID: 9154282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue.
    Diestelhorst M; Krieglstein GK; Lusky M; Nagasubramanian S
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S77-81. PubMed ID: 9154280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.